Molecular Genetic Analysis of Factor XI Deficiency: Identification of Five Novel Gene Alterations and the Origin of Type II Mutation in Portuguese Families

Summary

Coagulation factor XI (FXI) deficiency is an inherited autosomal recessive mild bleeding disorder. In this study, we report the molecular genetic analysis of FXI deficiency in six unrelated families of Portuguese origin. The Jewish type II mutation was found in two families, of seemingly Portuguese origin. Haplotype analysis in these families demonstrated that this mutation is of Jewish origin. In the remaining families, five novel FXI mutations have been identified. Two of these mutations (FXI IVS K -10T→A and FXI 1026G→T, cd 324) affect the FXI pre-mRNA splicing. A further two (FXI 307 ins AAGCAAT, cd 85 and FXI 1072 del A, cd 340) introduce frameshifts leading to premature termination codons. The FXI splicing mutation, 1026G→T cd 324, was found in compound heterozygosity with missense mutation FXI K518N. Analysis of the FXI mRNA from the latter genotype demonstrated new donor splice site usage. All reported mutations most likely result in functional null-alleles. In addition, three novel polymorphisms have been identified: at nt -138 in intron A, at codon D125 in exon 5 and at codon T249 in exon 8.

Key words

FXI deficiency - phenotype - FXI mutations - FXI pre-mRNA splicing - origin of the type II mutation

• References

• 1 Broze GJ, Gailani D. The role of factor XI in coagulation. Thromb Haemost 1993; 70: 72-4.
• 2 Gailani D, Broze GJ. Factor XI activation in a revised model of blood coagulation. Science 1991; 253: 909-12.
• 3 Ragni MV, Sinha D, Seaman F, Lewis JH, Spero JA, Walsh PN. Comparison of bleeding tendency, factor XI coagulant activity, and factor XI antigen in 25 factor XI-deficient kindreds. Blood 1985; 65: 719-24.
• 4 Shpilberg O, Peretz H, Zivelin A, Yatuv R, Chetrit A, Kulka T, Stern C, Weiss E, Seligsohn U. One of the common mutations causing factor XI deficiency in Ashkenazi-Jews (type II) is also prevalent in Iraqi Jews, who represent the ancient gene pool of Jews. Blood 1995; 85: 429-32.
• 5 Asakai R, Chung DW, Ratnoff OD, Davie EW. Factor XI (plasma thromboplastin antecedent) deficiency in Ashkenazi-Jews is a bleeding disorder that can result from three types of point mutations. Proc Natl Acad Sci USA 1989; 86: 7667-71.
• 6 Hancock JF, Wieland K, Pugh RE, Martinowitz U, Schulman S, Kakkar VV, Kernoff PBA, Cooper DN. A molecular genetic study of factor XI deficiency. Blood 1991; 77: 1942-8.
• 7 Peretz H, Zivelin A, Usher S, Seligsohn U. A 14-bp deletion (Codon 554 del AAGgtaacagagtg) at exon 14/intron N junction of the coagulation factor XI gene disrupts splicing and causes severe factor XI deficiency. Hum Mut 1996; 08: 77-8.
• 8 Peretz H, Mulai A, Usher S, Zivelin A, Segal A, Weisman Z, Mittelman M, Lupo H, Lanir N, Brenner B, Sphilberg O, Seligsohn U. The two mutations causing factor XI deficiency in Jews stem from distinct founders: one of ancient middle eastern origin and another of more recent European origin. Blood 1997; 90: 2654-9.
• 9 Pugh RE, McVey JH, Tuddenham EGD, Hanconk JH. Six point mutations that cause factor XI deficiency. Blood 1995; 85: 1509-16.
• 10 Imanaka Y, Lal K, Nishimura T, Bolton-Maggas PHB, Tuddenham EGD, McVey JH. Identification of two novel mutations in non-Jewish factor XI deficiency. Br J Haematol 1995; 90: 916-20.
• 11 Sato E, Kawamata N, Kato A, Oshimi K. A novel mutation that leads to a congenital factor XI deficiency in a Japanese family. Am J Hematol 2000; 63: 165-9.
• 12 Meijers JCM, Mulvihill ER, Davie EW, Chung DW. Apple four in human blood coagulation factor XI mediates dimer formation. Biochemistry 1992; 31: 4680-4.
• 13 Imanaka Y, McVey JH, Nishimura T, Bolton-Maggs P, Lloyd J, Tuddenham EGD. Identification and characterization of mutations in the factor XI gene of non-Jewish FXI deficient patients. Thromb Haemost 1993; 69: 763 (abstract).
• 14 Wistinghausen B, Reischer A, Oddoux C, Ostrer H, Nardi M, Karpatkin M. Severe factor XI deficiency in an Arab family associated with a novel mutation in exon 11. Br J Haematol 1997; 99: 575-7.
• 15 Martincic D, Zimmerman SA, Ware RE, Sun M-F, Whitlock JA, Gailani D. Identification of mutations and polymorphisms in the factor XI genes of an African American family by dideoxyfingerprinting. Blood 1998; 92: 3309-17.
• 16 Alhaq A, Mitchell M, Sethi M, Rahman S, Flynn G, Boulton P, Caeno G, Smith M, Savidge G. Identification of a novel mutation in a non-Jewish factor XI deficient kindred. Br J Haemat 1999; 104: 44-9.
• 17 Mitchell M, Cutler J, Thompson S, Moore G, Ap Rees EJ, Smith M, Savidge G, Alhaq A. Heterozygous factor XI deficiency associated with three novel mutations. Br J Haemat 1999; 107: 763-5.
• 18 Ohkubo Y, O’Brien DP, Kanehiro T, Fukui H, Tuddenham EGD. Characterisation of a panel of monoclonal antibodies to human coagulation factor XI and detection of factor XI in HepG2 conditioned medium. Thromb Haemost 1990; 63: 417-23.
• 19 Kirkwood TB, Snape TJ. Biometric principles in clotting and clot lysis assays. Clin Lab Haematol 1980; 02: 155-67.
• 20 David D, Moreira I, Lalloz MRA, Rosa HAV, Schwaab R, Morais S, Diniz MJ, de Deus G, Campos M, Lavinha J, Johnson D, Tuddenham EGD. Analysis of the essential sequences of the factor VIII gene in twelve haemophilia A patients by single-stranded conformation polymorphism. Blood Coagul Fibrinolysis 1994; 05: 257-64.
• 21 Bustorff TC, Freire I, Gago T, Crespo F, David D. Identification of three novel mutations in hereditary protein S deficiency. Thromb Haemost 1997; 77: 21-5.
• 22 Newton CR, Graham A, Heptinstall LE, Powell SJ, Summers C, Kalsheker N, Smith JC, Markham AF. Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS). Nucleic Acids Res 1989; 17: 2503-16.
• 23 Bertina RM, Koeleman BPC, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van der Velden PA, Reitsma PH. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64-7.
• 24 Schneider S, Kueffer J, Roselli D, Excoffier L. ARLEQUIN ver 1.1: A software for population genetic data analysis. Genetics and Biometry Laboratory; University of Geneva: 1997
• 25 Butler MG, Parsons AD. RFLP for intron E of factor XI gene. Nucleic Acids Res 1990; 18: 5327.
• 26 Bodfish P, Warne D, Watkins C, Nyberg K, Spurr NK. Dinucleotide repeat polymorphism in the human coagulation factor XI gene, intron B (F11), detected using the polymerase chain reaction. Nucleic Acids Res 1991; 19: 6979.
• 27 Cooper DN, Krawczak M. Mechanisms of insertional mutagenesis in human genes causing genetic disease. Hum Genet 1991; 87: 409-15.
• 28 David D, Rosa HAV, Pemberton S, Diniz MJ, Campos M, Lavinha J. Single-strand conformation polymorphism (SSCP) analysis of the molecular pathology of hemophilia B. Hum Mut 1993; 02: 355-61.
• 29 James HL, Girolami A, Fair DS. Molecular defect in coagulation factor XFriuli results from a substitution of serine for proline at position 343. Blood 1991; 77: 317-23.
• 30 Krawczak M, Reiss J, Cooper DN. The mutational spectrum of single basepair substitutions in mRNA splice junctions of human genes: causes and consequences. Hum Genet 1992; 90: 41-54.
• 31 Tavori S, Brenner B, Tatarsky I. The effect of combined factor XI deficiency with von Willebrand factor abnormalities on haemorrhagic diathesis. Throm Haemost 1990; 63: 36-8.
• 32 Berg LP, Varon D, Martinowitz U, Wieland K, Kakkar VV, Cooper DN. Combined factor VIII/factor XI deficiency may cause intrafamilial clinical variability in haemophilia A among Askenazi Jews. Blood Coagul Fibrinolysis 1994; 01: 59-62.
• 33 Nichols WC, Amano K, Cacheris PM, Figueiredo MS, Michaelides K, Schwaab R, Hoyer L, Kaufman RJ, Ginsburg D. Moderation of hemophilia A phenotype by the factor V R506Q mutation. Blood 1996; 88: 1183-7.
• 34 Arbini AA, Mannucci PM, Bauer KA. Low prevalence of the factor V Leiden mutation among “severe” hemophiliacs with a “milder” bleeding diathesis. Thromb Haemost 1995; 74: 1255-8.
• 35 Bouma BN, Meijers JCM. Fibrinolysis and the contact system: a role for factor XI in the down-regulation of fibrinolysis. Thromb Haemost 1999; 82: 243-50.